SCHEMBL6166942

SCHEMBL6166942

CC(C)Cc1nn(-c2ccc(Cl)nn2)c2c1C(=O)CCC2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
OPRM1 P35372 1/20 0.39
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
PANK3 Q9H999 2/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
SLC34A1 Q06495 1/20 0.32
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163994 0.87 HTT (0.39) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6166839 0.85 ALDH1A1 (0.50) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6163291 0.82 CCNA2 (0.42) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6162652 0.82 CCNA2 (0.45) LMNAALDH1A1CCNA2CDK2OPRM1
SCHEMBL6166364 0.82 CCNA2 (0.39) HTTLMNAALDH1A1CCNA2CDK2
SCHEMBL6166409 0.82 OPRM1 (0.56) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6164167 0.81 CCNA2 (0.38) ALDH1A1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6167013 0.80 CCNA2 (0.42) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6165207 0.78 ALDH1A1 (0.46) HTTLMNATSHRALDH1A1MAPT
SCHEMBL6770710 0.77 SRC (0.50) HTTLMNATSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed